According to the CDC, there are three medications used as part of treatment regimens in the U.S. for inactive TB — isoniazid, rifapentine, rifampin. The medications are used on their own or in ...

A groundbreaking drug, rifampin, could help to end the global tuberculosis epidemic, according to researchers. Clinical trials carried out at the McGill University Health Centre showed that ...

For adolescents aged 14 years and older and adults with rifampin-resistant pulmonary TB, a 6-month bedaquiline, pretomanid, and linezolid regimen is as efficacious and safe as the current 15-month ...

Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of rifampin-resistant tuberculosis, according to a study. The study tested five all ...

Sixty (61%) developed AKI within two months of anti-TB treatment, including 11 (11%) with a prior history of rifampin exposure. Thirty (30%) had co-morbid chronic kidney disease or end-stage renal ...

In children and adolescents with non-severe, drug-susceptible pulmonary TB, is a four-month regimen composed of standard-dose two months of isoniazid, rifampin, pyrazinamide, and ethambutol ...

TB treatment in HIV-positive patients is further complicated by drug-drug interactions between some of the antiretroviral agents (ARVs) and key antituberculous drugs, especially rifampin.

Since January 2024, dozens of tuberculosis cases have been found around Kansas City. TB may seem like a disease of the ...

Reviewing literature of rifampin-induced AKI ... [14,15] AKI during anti-TB treatment may be more common and serious in Taiwan, where more than 50% of TB patients are older than 65 years.